These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11242517)

  • 1. Inhibition of HIV type 1 replication by simultaneous infection of peripheral blood lymphocytes with human immunodeficiency virus types 1 and 2.
    Dern K; Rübsamen-Waigmann H; Unger RE
    AIDS Res Hum Retroviruses; 2001 Mar; 17(4):295-309. PubMed ID: 11242517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged infection of peripheral blood lymphocytes by Vif-negative HIV type 1 induces resistance to productive HIV type 1 infection through soluble factors.
    Simm M; Pekarskaya O; Potash MJ; Volsky DJ
    AIDS Res Hum Retroviruses; 2000 Jul; 16(10):943-52. PubMed ID: 10890355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
    Li XD; Moore B; Cloyd MW
    Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Productive infection of primary murine astrocytes, lymphocytes, and macrophages by human immunodeficiency virus type 1 in culture.
    Nitkiewicz J; Chao W; Bentsman G; Li J; Kim SY; Choi SY; Grunig G; Gelbard H; Potash MJ; Volsky DJ
    J Neurovirol; 2004 Dec; 10(6):400-8. PubMed ID: 15765811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary in vitro growth cycle and transmission studies of HIV-1 in an autologous primary cell assay of blood-derived macrophages and peripheral blood mononuclear cells.
    Tsai WP; Conley SR; Kung HF; Garrity RR; Nara PL
    Virology; 1996 Dec; 226(2):205-16. PubMed ID: 8955040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus-1 infection requires pertussis toxin sensitive G-protein-coupled signalling and mediates cAMP downregulation.
    Guntermann C; Murphy BJ; Zheng R; Qureshi A; Eagles PA; Nye KE
    Biochem Biophys Res Commun; 1999 Mar; 256(2):429-35. PubMed ID: 10079202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of HIV replication in lymphocytes and the efficacy of protease inhibitors.
    Bermejo M; Sánchez-Palomino S; Usán L; Alcamí J
    J Med Virol; 2004 Aug; 73(4):502-7. PubMed ID: 15221892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptotic killing of CD4+ T lymphocytes in HIV-1-infected PHA-stimulated PBL cultures is mediated by CD8+ LAK cells.
    Wang L; Klimpel GR; Planas JM; Li H; Cloyd MW
    Virology; 1998 Feb; 241(2):169-80. PubMed ID: 9499792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis induced in synchronized human immunodeficiency virus type 1-infected primary peripheral blood mononuclear cells is detected after the peak of CD4+ T-lymphocyte loss and is dependent on the tropism of the gp120 envelope glycoprotein.
    Lawson VA; Silburn KA; Gorry PR; Paukovic G; Purcell DF; Greenway AL; McPhee DA
    Virology; 2004 Sep; 327(1):70-82. PubMed ID: 15327899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and efficient cell-to-cell transmission of human immunodeficiency virus infection from monocyte-derived macrophages to peripheral blood lymphocytes.
    Carr JM; Hocking H; Li P; Burrell CJ
    Virology; 1999 Dec; 265(2):319-29. PubMed ID: 10600603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual phasic suppression of viral replication following de novo human immunodeficiency virus type 1 (HIV-1) infection in lymphocytes of asymptomatic HIV-1 carriers.
    Kannagi M; Nakamura T; Akari H; Kuroda MJ; Fujii M; Oka S; Iwamoto A; Kurata T; Higashi D; Harada S
    Leukemia; 1997 Apr; 11 Suppl 3():545-7. PubMed ID: 9209452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread.
    Toohey K; Wehrly K; Nishio J; Perryman S; Chesebro B
    Virology; 1995 Oct; 213(1):70-9. PubMed ID: 7483281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial inhibition of human immunodeficiency virus replication by type I interferons: impact of cell-to-cell viral transfer.
    Vendrame D; Sourisseau M; Perrin V; Schwartz O; Mammano F
    J Virol; 2009 Oct; 83(20):10527-37. PubMed ID: 19706714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restriction of HIV type 1 infection in macrophages heterozygous for a deletion in the CC-chemokine receptor 5 gene.
    Ometto L; Zanchetta M; Cabrelle A; Esposito G; Mainardi M; Chieco-Bianchi L; De Rossi A
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1441-52. PubMed ID: 10555107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-16 (IL-16) inhibits human immunodeficiency virus replication in cells from infected subjects, and serum IL-16 levels drop with disease progression.
    Amiel C; Darcissac E; Truong MJ; Dewulf J; Loyens M; Mouton Y; Capron A; Bahr GM
    J Infect Dis; 1999 Jan; 179(1):83-91. PubMed ID: 9841826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 in human alveolar macrophages from infected patients is latent in vivo but replicates after in vitro stimulation.
    Lebargy F; Branellec A; Deforges L; Bignon J; Bernaudin JF
    Am J Respir Cell Mol Biol; 1994 Jan; 10(1):72-8. PubMed ID: 8292383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte-tropic simian immunodeficiency virus causes persistent infection in the brains of rhesus monkeys.
    Stephens EB; Liu ZQ; Zhu GW; Adany I; Joag SV; Foresman L; Berman NE; Narayan O
    Virology; 1995 Nov; 213(2):600-14. PubMed ID: 7491784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory mechanism of anti-P30-52 monoclonal antibody against human immunodeficiency virus type 1 (HIV-1) multiplication in infected MT-4 cells.
    Ota A; Ueda S
    Hybridoma; 1999 Jun; 18(3):235-41. PubMed ID: 10475237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer of an anti-HIV-1 ribozyme gene into primary human lymphocytes.
    Leavitt MC; Yu M; Yamada O; Kraus G; Looney D; Poeschla E; Wong-Staal F
    Hum Gene Ther; 1994 Sep; 5(9):1115-20. PubMed ID: 7833371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.